Champlain Investment Partners, LLC Procept Bio Robotics Corp Transaction History
Champlain Investment Partners, LLC
- $12.7 Billion
- Q3 2025
A detailed history of Champlain Investment Partners, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 1,437,897 shares of PRCT stock, worth $42.7 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
1,437,897
Previous 1,070,646
34.3%
Holding current value
$42.7 Million
Previous $61.7 Million
16.78%
% of portfolio
0.41%
Previous 0.46%
Shares
9 transactions
Others Institutions Holding PRCT
# of Institutions
274Shares Held
49.1MCall Options Held
282KPut Options Held
384K-
Vanguard Group Inc Valley Forge, PA5.21MShares$155 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$103 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.42MShares$102 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.05MShares$60.9 Million0.04% of portfolio
-
Westfield Capital Management CO LP Boston, MA1.97MShares$58.5 Million0.32% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.32B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...